Champlain Investment Partners, LLC - MARAVAI LIFESCIENCES HLDGS I ownership

MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 195 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q2 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
Champlain Investment Partners, LLC ownership history of MARAVAI LIFESCIENCES HLDGS I
ValueSharesWeighting
Q2 2022$68,811,000
-45.5%
2,422,070
-32.4%
0.44%
-32.0%
Q1 2022$126,356,000
-15.2%
3,582,530
+0.8%
0.65%
-3.0%
Q4 2021$148,918,000
-7.6%
3,554,125
+8.2%
0.67%
-12.7%
Q3 2021$161,170,000
+11.8%
3,283,821
-5.0%
0.77%
+12.7%
Q2 2021$144,203,000
+136.7%
3,455,625
+102.2%
0.68%
+116.1%
Q1 2021$60,916,0001,709,2150.32%
Other shareholders
MARAVAI LIFESCIENCES HLDGS I shareholders Q2 2021
NameSharesValueWeighting ↓
GTCR LLC 21,681,033$1,064,105,00026.99%
Ghisallo Capital Management LLC 1,250,000$61,350,0002.33%
Beck Bode, LLC 160,064$7,856,0002.19%
Select Equity Group, L.P. 12,122,011$594,948,300,0002.00%
Pinz Capital Management, LP 83,603$4,103,0001.86%
Monashee Investment Management LLC 185,000$9,080,0001.68%
Ownership Capital B.V. 2,717,559$133,378,0001.51%
Eversept Partners, LP 327,810$16,088,9151.12%
Parkman Healthcare Partners LLC 90,000$4,417,0001.12%
Connacht Asset Management LP 28,569$1,402,0000.91%
View complete list of MARAVAI LIFESCIENCES HLDGS I shareholders